EUVIMEDDescubrir EUVIMED
KohortenstudieOpen access · CC BY 4.0

Long‐term outcome of ablation for anal HSIL : Achieving HSIL ‐free status is key—A UK ‐based retrospective cohort study

T Cuming iD, K Rozemeijer iD, E Farrow, C Cappello, B Wait, M Junejo iD, J Bowring, A N Rosenthal iD, O Richel, M Nathan iD, H J C de Vries iD, J M Prins

Colorectal Disease · 2026

DOI: 10.1111/codi.70596 ↗

At a glance

Kohortenstudie in Colorectal Disease, 2026. Written by T Cuming and 11 co-authors. Institution: Homerton University Hospital, London, UK. Major MEDLINE topics: Anus Neoplasms, Squamous Intraepithelial Lesions, Carcinoma, Squamous Cell, Laser Therapy. 21 references. The full text is freely available (open access, CC BY 4.0).

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Introduction

Treating anal high‐grade squamous intraepithelial lesions (HSIL) reduces squamous cell carcinoma (SCC) rates in high‐risk groups such as men having sex with men (MSM), especially those living with HIV (LWH). Follow‐up data after HSIL treatment is lacking.

Method

A retrospective analysis was conducted of consecutive male patients with biopsy‐proven HSIL undergoing high resolution anoscopy (HRA)‐based ablation and subsequent surveillance at a UK specialist centre until either latest HRA or cancer diagnosis. The primary objective was the proportion becoming HSIL‐free after treatment. Statistical analysis was carried out using time‐to‐event analysis with Cox proportional hazards and endpoints of anal cancer and HSIL recurrence.

Results

A total of 136 men, 88% MSM, 78% LWH, underwent surveillance for a median of 5.5 (interquartile range (IQR) 4.0–6.8) years after laser ablation of 188 HSILs of the perianus (26%) or anal canal (74%). After median 1 (IQR 1–2) ablations, 122/136 (90%) patients became HSIL‐free (definition: ≥ one HRA with cytology, free of HSIL), median 7 (IQR 5–14) months from index treatment. Fourteen of 136 (10%) patients never became HSIL‐free, of whom 5/14 (36%) developed SCC compared to 1/122 (0.8%) who were HSIL‐free at least once ( p < 0.01). All six patients developing SCC were MSMLWH. Never being HSIL‐free was associated with larger index lesions ( p < 0.001) and a CD4 nadir of

Subjects

MeSH terms (MEDLINE)

Anus NeoplasmsSquamous Intraepithelial LesionsCarcinoma, Squamous CellLaser TherapyHumansMaleRetrospective StudiesUnited KingdomTreatment OutcomeMiddle AgedNeoplasm Recurrence, LocalAnal CanalHomosexuality, MaleAgedTime FactorsAdultProctoscopy

Author keywords

HIV infectionsablation techniquesanal canceranal neoplasmscohort studiesfollow‐up studieshigh‐grade squamous intraepithelial lesionslaser therapyprecancerous conditionssexual and gender minoritiessquamous cell carcinoma

Authors and institutions

  • Homerton University Hospital, London, UK.
  • Imperial College, London, UK.
  • Department of Dermatology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Pathology, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Sloane Kettering, New York, USA.

ORCID profiles: T Cuming, K Rozemeijer, M Junejo, A N Rosenthal, M Nathan, H J C de Vries

Cite

APA

Cuming, T., Rozemeijer, K., Farrow, E., Cappello, C., Wait, B., Junejo, M., Bowring, J., Rosenthal, A. N., Richel, O., Nathan, M., de Vries, H. J. C., & Prins, J. M. (2026). Long‐term outcome of ablation for anal HSIL : Achieving HSIL ‐free status is key—A UK ‐based retrospective cohort study. Colorectal Disease. https://doi.org/10.1111/codi.70596

Vancouver

Cuming T, Rozemeijer K, Farrow E, Cappello C, Wait B, Junejo M, et al. Long‐term outcome of ablation for anal HSIL : Achieving HSIL ‐free status is key—A UK ‐based retrospective cohort study. Colorectal Disease. 2026. doi:10.1111/codi.70596

BibTeX
@article{Cuming2026,
  author = {Cuming, T and Rozemeijer, K and Farrow, E and Cappello, C and Wait, B and Junejo, M and Bowring, J and Rosenthal, A N and Richel, O and Nathan, M and de Vries, H J C and Prins, J M},
  title = {Long‐term outcome of ablation for anal HSIL : Achieving HSIL ‐free status is key—A UK ‐based retrospective cohort study},
  journal = {Colorectal Disease},
  year = {2026},
  doi = {10.1111/codi.70596}
}
Start for free →